Activities of agents involved in the wholesale of other particular products
ORION PHARMA AS
Revenue 2024
NOK 52.8m
Operating profit
NOK 9.5m
Equity
NOK 5.0m
Incorporated
1993
Employees
13
Share capital
NOK 800,000
Key figures · 2024
Current ratio
1.23
Equity ratio
22.1%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 17.9% | |
| Net margin (%%) | 14.6% | |
| Return on assets (%%) | 41.9% | |
| Likviditet | ||
| Current ratio | 1.23 | |
| Working capital | 4.0m | |
| Soliditet | ||
| Equity ratio (%%) | 22.1% | |
| Debt-to-equity ratio | 3.53 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.